Tag Archives: antibiotic

Amoxicillin shortage leaves kids waiting in emergency rooms for hours

Revelations 18:23:’For the merchants were the great men of the earth; for by thy sorceries were all nations deceived.’

Important Takeaways:

  • Children are left waiting for 15 HOURS in emergency rooms due to Amoxicillin shortage caused by COVID restrictions – as record number of parents are forced to take time off work to care for sick kids
  • Amid an ongoing Amoxicillin shortage, hospitals are seeing rising numbers of RSV cases that are unable to be treated by the common antibiotic
  • Parents are struggling to fill their children’s prescriptions as major pharmacies fail to fill demand that suppliers struggle to meet
  • Experts say COVID lockdowns caused weakened immune systems in children that are now particularly susceptible to a rough few months of seasonal viruses
  • Parents have also been forced to stay home from jobs without sick leave pay to care for ill children, which is costing families financially

Read the original article by clicking here.

Warning shortage of Amoxicillin FDA blames surge on respiratory illness

Revelations 18:23:’For the merchants were the great men of the earth; for by thy sorceries were all nations deceived.’

Important Takeaways:

  • U.S. is running out of common children’s antibiotic amoxicillin – forcing parents to shop around multiple pharmacies
  • Four Drugmakers behind nearly the entire country’s supply are facing a shortage
  • The liquid form of the medication is in short supply, they said
  • Officials made aware last month when patients struggled to fill prescriptions
  • The Food and Drug Association (FDA) blamed a surge in demand for the shortage — with respiratory illnesses at unseasonably high levels.
  • Amoxicillin is a common antibiotic prescribed to children to treat ear and sinus infections.

Read the original article by clicking here.

G7 told to act on antibiotics as dreaded superbug hits U.S.

Colonies of E. coli bacteria are seen in a microscopic image courtesy of the CDC

By Kylie MacLellan and Ben Hirschler

ISE-SHIMA, Japan/LONDON (Reuters) – Britain told the G7 industrial powers on Friday to do more to fight killer superbugs as the United States reported the first case in the country of a patient with bacteria resistant to a last-resort antibiotic.

U.S. scientists said the infection in a 49-year-old Pennsylvania woman “heralds the emergence of truly pan-drug resistant bacteria” because it could not be controlled even by colistin, an antibiotic reserved for “nightmare” bugs.

In Japan, British Prime Minister David Cameron said leading countries needed to tackle resistance by reducing the use of antibiotics and rewarding drug companies for developing new medicines.

“In too many cases antibiotics have stopped working. That means people are dying of simple infections or conditions like TB (tuberculosis), tetanus, sepsis, infections that should not mean a death sentence,” he told a news conference at a summit in Japan.

“If we do nothing about this there will be a cumulative hit to the world economy of $100 trillion and it is potentially the end of modern medicine as we know it.”

A review commissioned by the British government and published last week said a reward of between $1 billion and $1.5 billion should be paid for any successful new antimicrobial medicine brought to market.

If the problem is not brought under control, antimicrobial resistance could kill an extra 10 million people a year by 2050, the review warned.

The U.S. case is a further wake-up call for the world, although it is not the first time that colistin resistance has appeared.

Medics around were alarmed last year by the discovery in China of a new gene that makes bacteria highly resistant to the medicine. Since then, the deadly strain has also been detected in Europe and Canada.

The development of colistin resistance is linked to the drug’s widespread use in livestock and the European Medicines Agency on Thursday called for a 65 percent cut in the amount of the medicine used in farming.

“The more we look at drug resistance, the more concerned we are,” Thomas Frieden, director of the U.S. Centers for Disease Control and Prevention, told reporters in Washington.

“The medicine cabinet is empty for some patients. It is the end of the road for antibiotics unless we act urgently.”

The problem is aggravated by drugmakers’ reluctance to invest in developing new antibiotics, preferring to focus on more profitable disease areas, although recently there has been some increase in investment, prompted by the superbug threat.

In January, 83 companies, including Pfizer, Merck, MRK., Johnson & Johnson JNJ.N and GlaxoSmithKline, signed a declaration urging governments to support work on new antibiotics.

(Reporting by Kylie MacLellan; Writing by Elizabeth Piper; Editing by Louise Ireland)

WHO Declares Post-Antibiotic Age Is Here

The United Nations has declared the world is now officially in the post-antibiotic age.

The World Health Organization said Wednesday that the discussion regarding the emergence of antibiotic resistant bacteria is no longer a theoretical discussion and a harsh reality that the world needs to confront.

“The implications will be devastating,” the WHO said in a report.

The WHO report included shocking information. The report shows that the most well known of the “superbugs”, MRSA, will kill more people in the United States than AIDS.  The report says a similar situation will occur this year in Europe.

International aid groups are joining the WHO in raising the alarm.

“We see horrendous rates of antibiotic resistance wherever we look in our field operations, including children admitted to nutritional centers in Niger, and people in our surgical and trauma units in Syria,” Jennifer Cohn of Doctors Without Borders told Fox.